By

Sara Dagen

Sid Martin Biotech Alum DiaCarta’s Biomarker Algorithm Predicts Response and Outcome of Chemotherapy

UF Innovate | Sid Martin Biotech alum DiaCarta Inc., a precision molecular diagnostics company with proprietary technologies for the development of novel liquid biopsy oncology tests, announced the publication of a study in Nature Scientific Reports that demonstrates the company's cfDNA biomarker algorithm could function as a prognostic biomarker and efficacy predictor for non-small cell lung cancer (NSCLC) patients.

Resilience Acquires Biologics Manufacturing Company Ology Bioservices

Resilience, a company building the world’s most advanced biopharmaceutical manufacturing ecosystem, announced it has acquired Ology Bioservices, Inc., a privately held company that also specializes in biologic drug substance manufacturing from early-stage through commercial products.